Metabolon Announces Collaboration with the University of Texas Health Science Center at San Antonio

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced that it is collaborating with Ralph A. DeFronzo, M.D. and colleagues at The University of Texas Health Science Center at San Antonio. The partnership will help drive development of Metabolon’s pre-diabetes diagnostic products as well as provide valuable data for insulin resistance and diabetes-related research.